非药物干预措施预防阿尔茨海默病的研究进展
Research Progress on Non-Pharmacological Interventions to Prevent Alzheimer’s Disease
DOI: 10.12677/OJNS.2023.113042, PDF,    科研立项经费支持
作者: 翁 湄*, 张心仪, 徐加伟:宁德师范学院医学院,福建 宁德;苏裕盛#:宁德师范学院医学院,福建 宁德;宁德师范学院毒物与药物毒理学重点实验室,福建 宁德
关键词: 阿尔茨海默病非药物干预Alzheimer Disease Non-Pharmacologic Treatments β-Amyloid Protein
摘要: 阿尔茨海默病(Alzheimer disease, AD)是一种常见的失智形式,其生理学定义为β淀粉样蛋白(β-amyloid protein, Aβ)的聚集和含Tau的神经原纤维缠结。导致典型表现形式是遗忘型认知功能损害和不太常见变体的非遗忘认知功能损害。研究人员发现了许多有效的非药物治疗(non-pharmacologic treatments, NPT)的手段,并且流行病学研究已经确定了许多有希望的非药物干预的方法,不仅有可以降低发生失智症的风险,还可以在已经患有失智症的情况下起到作用。对失智患者的非药物干预旨在改善生活质量和福祉,在药物治疗的领域尚无令人满意的措施下,这些方法也变得越来越重要。本文介绍了远离孤独,芳香疗法,动物辅助,针灸,多感官刺激对AD的影响,这些方法在行为认知功能情绪等方面对AD有一定的影响,还可以促进沟通技巧和社会参与。这些非药物干预措施对于提高AD病患者和高风险人群的生活质量和认知功能有一定的帮助,但仍需要更多的临床试验和长期随访来确定其安全性和有效性。
Abstract: Alzheimer’s disease (AD), a common form of dementia, is physiologically defined by the accumulation of β-amyloid and tau-containing neurofibrillary tangles. It typically manifests as amnestic cognitive impairment and less common variants of non-amnestic cognitive impairment. Researchers have found many effective non-pharmacological treatments (NPT), and epidemiological studies have identified many promising NPT that can not only reduce the risk of developing dementia, but also improve the effect of dementia in those who already have it. NPT aimed at improving the quality of life and well-being of people with dementia are becoming increasingly important in the absence of satisfactory measures in the field of pharmacological treatment. This article introduces the effects of keeping away from loneliness, aromatherapy, animal assistance, acupuncture, and multi-sensory stimulation on advertising. These methods have certain effects on advertising in terms of behavior, cognitive function, emotion, etc., and can also promote communication skills and social participation. These NPT are helpful to improve the quality of life and cognitive function of patients with AD and high-risk populations, but more clinical trials and long-term follow-up are still needed to determine their safety and efficacy.
文章引用:翁湄, 张心仪, 徐加伟, 苏裕盛. 非药物干预措施预防阿尔茨海默病的研究进展[J]. 自然科学, 2023, 11(3): 351-360. https://doi.org/10.12677/OJNS.2023.113042

参考文献

[1] Beata, B.K., Wojciech, J., Johannes, K., et al. (2023) Alzheimer’s Disease-Biochemical and Psychological Back-ground for Diagnosis and Treatment. International Journal of Molecular Sciences, 24, Article No. 1059. [Google Scholar] [CrossRef] [PubMed]
[2] Yu, T.W., Lane, H.Y. and Lin, C.H. (2021) Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review. International Journal of Molecular Sciences, 22, Article No. 8208. [Google Scholar] [CrossRef] [PubMed]
[3] Scheltens, P., De Strooper, B., Kivipelto, M., et al. (2021) Alzheimer’s Disease. The Lancet, 397, 1577-1590. [Google Scholar] [CrossRef
[4] Breijyeh, Z. and Karaman, R. (2020) Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules, 25, Article No. 5789. [Google Scholar] [CrossRef] [PubMed]
[5] Bakota, L. and Brandt, R. (2016) Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease. Drugs, 76, 301-313. [Google Scholar] [CrossRef] [PubMed]
[6] Mandelkow, E.M. and Mandelkow, E. (1998) Tau in Alz-heimer’s Disease. Trends in Cell Biology, 8, 425-427. [Google Scholar] [CrossRef
[7] Martin, L., Latypova, X., Wilson, C.M., et al. (2013) Tau Protein Kinases: Involvement in Alzheimer’s Disease. Ageing Research Reviews, 12, 289-309. [Google Scholar] [CrossRef] [PubMed]
[8] Mandelkow, E.M. and Mandelkow, E. (1994) Tau Protein and Alzheimer’s Disease. Neurobiology of Aging, 15, S85-S86. [Google Scholar] [CrossRef] [PubMed]
[9] Ng, P.Y., Chang, I.S., Koh, R.Y., et al. (2020) Recent Advances in Tau-Directed Immunotherapy against Alzheimer’s Disease: An Overview of Pre-Clinical and Clinical Development. Metabolic Brain Disease, 35, 1049-1066. [Google Scholar] [CrossRef] [PubMed]
[10] Sery, O., Povova, J., Misek, I., et al. (2013) Molecular Mechanisms of Neuropathological Changes in Alzheimer’s Disease: A Review. Folia Neuropathologica, 51, 1-9. [Google Scholar] [CrossRef] [PubMed]
[11] Castellani, R.J., Plascencia-Villa, G. and Perry, G. (2019) The Amyloid Cascade and Alzheimer’s Disease Therapeutics: Theory versus Observation. Laboratory Investigation, 99, 958-970. [Google Scholar] [CrossRef] [PubMed]
[12] Passeri, E., Elkhoury, K., Morsink, M., et al. (2022) Alzheimer’s Disease: Treatment Strategies and Their Limitations. International Journal of Molecular Sciences, 23, Article No. 13954. [Google Scholar] [CrossRef] [PubMed]
[13] Pinheiro, L. and Faustino, C. (2019) Thera-peutic Strategies Targeting Amyloid-beta in Alzheimer’s Disease. Current Alzheimer Research, 16, 418-452. [Google Scholar] [CrossRef] [PubMed]
[14] Yamazaki, Y. and Kanekiyo, T. (2017) Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease. International Journal of Molecular Sciences, 18, Article No. 1965. [Google Scholar] [CrossRef] [PubMed]
[15] Sun, X., Chen, W.D. and Wang, Y.D. (2015) beta-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease. Frontiers in Pharmacology, 6, Article No. 221. [Google Scholar] [CrossRef] [PubMed]
[16] Solis, E.J., Hascup, K.N. and Hascup, E.R. (2020) Alzheimer’s Disease: The Link between Amyloid-beta and Neurovascular Dysfunction. Journal of Alz-heimer’s Disease, 76, 1179-1198. [Google Scholar] [CrossRef
[17] Hamel, E., Nicolakakis, N., Aboulkassim, T., et al. (2008) Oxidative Stress and Cerebrovascular Dysfunction in Mouse Models of Alzheimer’s Disease. Experimental Physiology, 93, 116-120. [Google Scholar] [CrossRef] [PubMed]
[18] Love, S. and Miners, J.S. (2016) Cerebrovascular Dis-ease in Ageing and Alzheimer’s Disease. Acta Neuropathologica, 131, 645-658. [Google Scholar] [CrossRef] [PubMed]
[19] Ojo, J.O., Reed, J.M., Crynen, G., et al. (2021) APOE Gen-otype Dependent Molecular Abnormalities in the Cerebrovasculature of Alzheimer’s Disease and Age-Matched Non-Demented Brains. Molecular Brain, 14, Article No. 110. [Google Scholar] [CrossRef] [PubMed]
[20] Serrano-Pozo, A., Das, S. and Hyman, B.T. (2021) APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches. The Lancet Neu-rology, 20, 68-80. [Google Scholar] [CrossRef
[21] Hansen, D.V., Hanson, J.E. and Sheng, M. (2018) Mi-croglia in Alzheimer’s Disease. Journal of Cell Biology, 217, 459-472. [Google Scholar] [CrossRef] [PubMed]
[22] Singh, D. (2022) Astrocytic and Microglial Cells as the Modulators of Neuroinflammation in Alzheimer’s Disease. Journal of Neuroinflammation, 19, Article No. 206. [Google Scholar] [CrossRef] [PubMed]
[23] Li, Q., Wu, Y., Chen, J., et al. (2022) Microglia and Im-munotherapy in Alzheimer’s Disease. Acta Neurologica Scandinavica, 145, 273-278. [Google Scholar] [CrossRef] [PubMed]
[24] Cai, Z., Hussain, M.D. and Yan, L.J. (2014) Microglia, Neuroinflam-mation, and beta-Amyloid Protein in Alzheimer’s Disease. International Journal of Neuroscience, 124, 307-321. [Google Scholar] [CrossRef] [PubMed]
[25] Acosta, C. anderson, H.D. and Anderson, C.M. (2017) Astrocyte Dysfunction in Alzheimer Disease. Journal of Neuroscience Research, 95, 2430-2447. [Google Scholar] [CrossRef] [PubMed]
[26] Carter, S.F., Herholz, K., Rosa-Neto, P., et al. (2019) Astrocyte Bi-omarkers in Alzheimer’s Disease. Trends in Molecular Medicine, 25, 77-95. [Google Scholar] [CrossRef] [PubMed]
[27] Nanclares, C., Baraibar, A.M., Araque, A., et al. (2021) Dysregulation of Astrocyte-Neuronal Communication in Alzheimer’s Disease. International Journal of Molecular Sciences, 22, Article No. 7887. [Google Scholar] [CrossRef] [PubMed]
[28] Batarseh, Y.S., Duong, Q.V., Mousa, Y.M., et al. (2016) Amy-loid-beta and Astrocytes Interplay in Amyloid-beta Related Disorders. International Journal of Molecular Sciences, 17, Article No. 338. [Google Scholar] [CrossRef] [PubMed]
[29] Cai, Z., Wan, C.Q. and Liu, Z. (2017) Astrocyte and Alzheimer’s Disease. Journal of Neurology, 264, 2068-2074. [Google Scholar] [CrossRef] [PubMed]
[30] Berg-Weger, M. and Stewart, D.B. (2017) Non-Pharmacologic Interventions for Persons with Dementia. Missouri Medicine, 114, 116-119.
[31] Shigihara, Y., Hoshi, H., Poza, J., et al. (2020) Predicting the Outcome of Non-Pharmacological Treatment for Patients with De-mentia-Related Mild Cognitive Impairment. Aging (Albany NY), 12, 24101-24116. [Google Scholar] [CrossRef] [PubMed]
[32] Akhter-Khan, S.C., Tao, Q., Ang, T., et al. (2021) Associations of Loneliness with Risk of Alzheimer’s Disease Dementia in the Framingham Heart Study. Alzheimer’s & Dementia, 17, 1619-1627. [Google Scholar] [CrossRef] [PubMed]
[33] Avila-Villanueva, M., Gomez-Ramirez, J., Avila, J., et al. (2022) Loneliness as Risk Factor for Alzheimer’s Disease. Current Aging Science, 15, 293-296. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, Y., Tatewaki, Y., Liu, Y., et al. (2022) Perceived Social Isolation Is Correlated with Brain Structure and Cognitive Trajectory in Alzheimer’s Disease. Geroscience, 44, 1563-1574. [Google Scholar] [CrossRef] [PubMed]
[35] Victor, C.R. (2020) Is Lone-liness a Cause or Consequence of Dementia? A Public Health Analysis of the Literature. Frontiers in Psychology, 11, Article ID: 612771. [Google Scholar] [CrossRef] [PubMed]
[36] Sutin, A.R., Stephan, Y., Luchetti, M., et al. (2020) Loneliness and Risk of Dementia. Journals of Gerontology—Series B Psychological Sciences and Social Sciences, 75, 1414-1422. [Google Scholar] [CrossRef] [PubMed]
[37] Sundstrom, A., Adolfsson, A.N., Nordin, M., et al. (2020) Loneliness Increases the Risk of All-Cause Dementia and Alzheimer’s Disease. Journals of Ger-ontology—Series B Psychological Sciences and Social Sciences, 75, 919-926. [Google Scholar] [CrossRef] [PubMed]
[38] Lara, E., Martin-Maria, N., De la Torre-Luque, A., et al. (2019) Does Loneliness Contribute to Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis of Longitudinal Studies. Ageing Research Reviews, 52, 7-16. [Google Scholar] [CrossRef] [PubMed]
[39] Moyle, W., Kellett, U., Ballantyne, A., et al. (2011) Dementia and Loneliness: An Australian Perspective. Journal of Clinical Nursing, 20, 1445-1453. [Google Scholar] [CrossRef] [PubMed]
[40] Ball, E.L., Owen-Booth, B., Gray, A., et al. (2020) Aromatherapy for Dementia. Cochrane Database of Systematic Reviews, 8, D3150. [Google Scholar] [CrossRef
[41] Yang, M.H., Lin, L.C., Wu, S.C., et al. (2015) Com-parison of the Efficacy of Aroma-Acupressure and Aromatherapy for the Treatment of Dementia-Associated Agi-tation. BMC Complementary and Alternative Medicine, 15, Article No. 93. [Google Scholar] [CrossRef] [PubMed]
[42] Fung, J. and Tsang, H.W. (2018) Management of Behavioural and Psychological Symptoms of Dementia by an Aroma-Massage with Acupressure Treatment Protocol: A Ran-domised Clinical Trial. Journal of Clinical Nursing, 27, 1812-1825. [Google Scholar] [CrossRef] [PubMed]
[43] Jimbo, D., Kimura, Y., Taniguchi, M., et al. (2009) Effect of Aro-matherapy on Patients with Alzheimer’s Disease. Psychogeriatrics, 9, 173-179. [Google Scholar] [CrossRef] [PubMed]
[44] Ebihara, T., Yamasaki, M., Kozaki, K., et al. (2021) Medical Aromatherapy in Geriatric Syndrome. Geriatrics & Gerontology International, 21, 377-385. [Google Scholar] [CrossRef] [PubMed]
[45] Faridzadeh, A., Salimi, Y., Ghasemirad, H., et al. (2022) Neuroprotec-tive Potential of Aromatic Herbs: Rosemary, Sage, and Lavender. Frontiers in Neuroscience, 16, Article ID: 909833. [Google Scholar] [CrossRef] [PubMed]
[46] Ghasemzadeh, R.M. and Hosseinzadeh, H. (2020) Therapeu-tic Effects of Rosemary (Rosmarinus officinalis L.) and Its Active Constituents on Nervous System Disorders. Ira-nian Journal of Basic Medical Sciences, 23, 1100-1112.
[47] Urakami, K. (2022) Dementia Prevention and Aro-matherapy in Japan. Yonago Acta Medica, 65, 184-190. [Google Scholar] [CrossRef] [PubMed]
[48] Wang, L.Y., Pei, J., Zhan, Y.J., et al. (2020) Overview of Meta-Analyses of Five Non-Pharmacological Interventions for Alzheimer’s Disease. Frontiers in Aging Neurosci-ence, 12, Article ID: 594432. [Google Scholar] [CrossRef] [PubMed]
[49] Teja, Y., Helianthi, D.R. and Nareswari, I. (2021) The Role of Medical Acupuncture Therapy in Alzheimer’s Disease. Medical Acupuncture, 33, 396-402. [Google Scholar] [CrossRef] [PubMed]
[50] Zhou, H., Sun, G., Kong, L., et al. (2014) Acupuncture and Moxibustion Reduces Neuronal Edema in Alzheimer’s Disease Rats. Neural Regeneration Research, 9, 968-972. [Google Scholar] [CrossRef] [PubMed]
[51] Harris, M.L., Titler, M.G. and Struble, L.M. (2020) Acu-puncture and Acupressure for Dementia Behavioral and Psychological Symptoms: A Scoping Review. Western Journal of Nursing Research, 42, 867-880. [Google Scholar] [CrossRef] [PubMed]
[52] Yin, W., Lv, G., Li, C., et al. (2021) Acupuncture Therapy for Alzheimer’s Disease: The Effectiveness and Potential Mechanisms. The Anatomical Record (Hoboken), 304, 2397-2411. [Google Scholar] [CrossRef] [PubMed]
[53] Wuli, W., Harn, H.J., Chiou, T.W., et al. (2021) Chinese Herbs and Acupuncture to Improve Cognitive Function in Alzheimer’s Disease. Tzu Chi Medical Journal, 33, 122-127. [Google Scholar] [CrossRef] [PubMed]
[54] Yakimicki, M.L., Edwards, N.E., Richards, E., et al. (2019) Animal-Assisted Intervention and Dementia: A Systematic Review. Clinical Nursing Research, 28, 9-29. [Google Scholar] [CrossRef] [PubMed]
[55] Rodrigo-Claverol, M., Malla-Clua, B., Marquilles-Bonet, C., et al. (2020) Animal-Assisted Therapy Improves Communication and Mobility among Institutionalized People with Cognitive Impairment. International Journal of Environmental Research and Public Health, 17, Article No. 5899. [Google Scholar] [CrossRef] [PubMed]
[56] Nordgren, L. and Engstrom, G. (2014) Animal-Assisted Inter-vention in Dementia: Effects on Quality of Life. Clinical Nursing Research, 23, 7-19. [Google Scholar] [CrossRef] [PubMed]
[57] Park, S., Bak, A., Kim, S., et al. (2020) Animal-Assisted and Pet-Robot Interventions for Ameliorating Behavioral and Psychological Symptoms of Dementia: A Systematic Re-view and Meta-Analysis. Biomedicines, 8, Article No. 150. [Google Scholar] [CrossRef] [PubMed]
[58] Scales, K., Zimmerman, S. and Miller, S.J. (2018) Evi-dence-Based Nonpharmacological Practices to Address Behavioral and Psychological Symptoms of Dementia. Gerontologist, 58, S88-S102. [Google Scholar] [CrossRef] [PubMed]
[59] Nordgren, L. and Engstrom, G. (2012) Effects of Animal-Assisted Therapy on Behavioral and/or Psychological Symptoms in Dementia: A Case Report. American Journal of Alzheimer’s Disease & Other Dementias, 27, 625-632. [Google Scholar] [CrossRef] [PubMed]
[60] Buettner, L.L., Fitzsimmons, S. and Barba, B. (2011) Ani-mal-Assisted Therapy for Clients with Dementia. Journal of Gerontological Nursing, 37, 10-14. [Google Scholar] [CrossRef] [PubMed]
[61] Kim, S., Nam, Y., Ham, M.J., et al. (2021) Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer’s Disease: A Hypothetical Review. Frontiers in Aging Neuroscience, 13, Article ID: 682308. [Google Scholar] [CrossRef] [PubMed]
[62] Lai, N.M., Chang, S., Ng, S.S., et al. (2019) Animal-Assisted Therapy for Dementia. Cochrane Database of Systematic Reviews, 2019, CD013243. [Google Scholar] [CrossRef
[63] Swall, A., Ebbeskog, B., Lundh, H.C., et al. (2017) Stepping Out of the Shadows of Alzheimer’s Disease: A Phenomenological Hermeneutic Study of Older People with Alzheimer’s Disease Caring for a Therapy Dog. International Journal of Qualitative Studies on Health and Well-Being, 12, Article ID: 1347013. [Google Scholar] [CrossRef] [PubMed]
[64] Takeda, M., Tanaka, T., Okochi, M., et al. (2012) Non-Pharmacological Intervention for Dementia Patients. Psychiatry and Clinical Neurosciences, 66, 1-7. [Google Scholar] [CrossRef] [PubMed]
[65] Maseda, A., Cibeira, N., Lorenzo-Lopez, L., et al. (2018) Multisensory Stimulation and Individualized Music Sessions on Older Adults with Severe Dementia: Effects on Mood, Behavior, and Biomedical Parameters. Journal of Alzheimer’s Disease, 63, 1415-1425. [Google Scholar] [CrossRef
[66] Maseda, A., Sanchez, A., Marante, M.P., et al. (2014) Effects of Multisensory Stimulation on a Sample of Institutionalized Elderly People with Dementia Diagnosis: A Controlled Longitudinal Trial. American Journal of Alzheimer’s Disease & Other Dementias, 29, 463-473. [Google Scholar] [CrossRef] [PubMed]
[67] Sanchez, A., Marante-Moar, M.P., Sarabia, C., et al. (2016) Multisensory Stimulation as an Intervention Strategy for Elderly Patients with Severe Dementia: A Pilot Randomized Controlled Trial. American Journal of Alzheimer’s Disease & Other Dementias, 31, 341-350. [Google Scholar] [CrossRef] [PubMed]
[68] Silva, R., Abrunheiro, S., Cardoso, D., et al. (2018) Effec-tiveness of Multisensory Stimulation in Managing Neuropsychiatric Symptoms in Older Adults with Major Neu-rocognitive Disorder: A Systematic Review. JBI Database of Systematic Reviews and Implementation Reports, 16, 1663-1708. [Google Scholar] [CrossRef
[69] Sanchez, A., Millan-Calenti, J.C., Lo-renzo-Lopez, L., et al. (2013) Multisensory Stimulation for People with Dementia: A Review of the Literature. American Journal of Alzheimer’s Disease & Other Dementias, 28, 7-14. [Google Scholar] [CrossRef] [PubMed]
[70] Machado, B.M. and Castro, C. (2022) Use of Multisensory Stimulation in Institutionalized Older Adults with Moderate or Severe Dementia. Dementia & Neuropsychologia, 16, 202-212. [Google Scholar] [CrossRef] [PubMed]
[71] Rodriguez-Gonzalez, V., Gomez, C., Hoshi, H., et al. (2021) Exploring the Interactions between Neurophysiology and Cognitive and Behavioral Changes In-duced by a Non-Pharmacological Treatment: A Network Approach. Frontiers in Aging Neuroscience, 13, Article ID: 696174. [Google Scholar] [CrossRef] [PubMed]
[72] Herholz, S.C., Herholz, R.S. and Herholz, K. (2013) Non-Pharmacological Interventions and Neuroplasticity in Early Stage Alzheimer’s Disease. Expert Review of Neurotherapeutics, 13, 1235-1245. [Google Scholar] [CrossRef] [PubMed]
[73] Shigihara, Y., Hoshi, H., Shinada, K., et al. (2020) Non-Pharmacological Treatment Changes Brain Activity in Patients with Dementia. Scientific Reports, 10, Article No. 6744. [Google Scholar] [CrossRef] [PubMed]